Details for New Drug Application (NDA): 079085
✉ Email this page to a colleague
NDA 079085 describes CARBIDOPA, LEVODOPA AND ENTACAPONE, which is a drug marketed by Norvium Bioscience, Rising, Sun Pharm, and Wockhardt Ltd, and is included in five NDAs. It is available from one supplier. Additional details are available on the CARBIDOPA, LEVODOPA AND ENTACAPONE profile page.
The generic ingredient in CARBIDOPA, LEVODOPA AND ENTACAPONE is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
The generic ingredient in CARBIDOPA, LEVODOPA AND ENTACAPONE is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
Summary for 079085
| Tradename: | CARBIDOPA, LEVODOPA AND ENTACAPONE |
| Applicant: | Sun Pharm |
| Ingredient: | carbidopa; entacapone; levodopa |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;200MG;100MG | ||||
| Approval Date: | May 10, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 37.5MG;200MG;150MG | ||||
| Approval Date: | May 10, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
